Figure 1.
Risk for progression to myeloma or related disorder in 306 patients with SMM, using a PCPI cutoff of 0.5.

Risk for progression to myeloma or related disorder in 306 patients with SMM, using a PCPI cutoff of 0.5.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal